https://european-biotechnology.net/wp-content/uploads/2025/05/KU-Leuven_aliaksandr_adobe-stock-e1747207729161.jpg5631000Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-14 07:29:342025-05-14 07:29:34eXmoor Pharma and KU Leuven join forces in AAV production
https://european-biotechnology.net/wp-content/uploads/2025/05/SLAS_Europe_Ignite-Award-winner-scaled-e1733133605635-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-08 09:26:412025-05-14 15:32:03SLAS names SLAS Europe Award finalists
https://european-biotechnology.net/wp-content/uploads/2025/05/money-bag-1189868_1280.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-07 09:02:382025-05-07 09:02:38Lilly pays US$415m for rights to ATLX-1282
https://european-biotechnology.net/wp-content/uploads/2025/05/Dynamic42_Tumor_on_Chip_sm-768x512-1.jpg512768Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-06 16:15:452025-05-06 16:15:45Dynamic42 GmbH starts distribution of organ-on-chip to the US and Canada
